Advanced Drainage Systems (WMS) Q4 2026 earnings review
M&A Boosts Revenue, But Deal Costs Crush GAAP Earnings
Advanced Drainage Systems (ADS) delivered a 10% top-line increase in Q4, entirely driven by the integration of the recently acquired National Diversified Sales (NDS) business. However, beneath the headline beat, organic Stormwater growth was a meager 2%. The bottom line suffered a massive 54% collapse in GAAP Net Income as integration and transaction costs drove a 50% spike in SG&A. Encouragingly, Adjusted EBITDA held up, growing 6.4% and proving the underlying model remains cash-generative. Looking ahead to FY27, management is cautious on residential construction but expects NDS to fuel double-digit revenue growth, though implied guidance points to slight margin compression.
🐂 Bull Case
The business model proved highly cash-generative. Free Cash Flow surged 54% to $569.3M for the full year, providing ample liquidity to digest the NDS acquisition and keep net leverage at a healthy 1.6x.
The strategic transition toward higher-margin Infiltrator and Allied products (now 48% of total revenue) structuralized higher profitability, allowing the company to expand its FY26 Adjusted EBITDA margin by 100 bps to 31.6%.
🐻 Bear Case
Despite a 10% jump in total Q4 revenue, organic Stormwater sales only grew 2%. The company is heavily reliant on M&A to mask a sluggish macro environment.
Selling, General, and Administrative expenses skyrocketed 50.5% in Q4, consuming over 20% of net sales. If integration costs remain elevated, they threaten to dilute the margin gains achieved through product mix.
⚖️ Verdict: ⚪
Neutral. ADS is executing well on its structural shift toward higher-margin segments, and Free Cash Flow is exceptional. However, the heavy reliance on M&A to drive growth, coupled with a deteriorating GAAP profit profile from integration costs and a cautious organic demand outlook, warrants a balanced view.
Key Themes
SG&A Expense Explosion
Selling, general and administrative expenses surged 50.5% YoY to $137.6M in Q4, representing a massive 20.3% of sales compared to 14.8% a year ago. Management attributed this to the NDS acquisition and associated transaction costs. While some of these are one-time items, the sheer magnitude of the spike severely depressed Net Income and highlights the execution risk inherent in integrating a large acquisition.
NDS Acquisition Plugs the Growth Gap
The February closing of the NDS acquisition was the sole reason ADS posted impressive Q4 top-line numbers. NDS contributed $48.8M to the Stormwater segment, masking what would have otherwise been an underwhelming quarter. This positions ADS deeper into residential stormwater and irrigation, but makes the company heavily dependent on cross-selling synergies to justify the deal.
Organic Volume Fails to Match Headline Growth
A contradicting narrative exists beneath the strong 10% Q4 revenue growth: organic Stormwater sales increased a mere 2%. Furthermore, Wastewater sales growth heavily decelerated, proving that the underlying macro demand—especially in residential construction—remains deeply challenged despite the rosy reported totals.
Wastewater Segment Sharply Decelerating
The Wastewater segment (primarily Infiltrator) went from being the company's powerhouse growth engine to a laggard. After posting +21% and +25% YoY growth in Q1 and Q2, growth slowed to just +3.7% YoY in Q4 ($142.0M). This dramatic deceleration signals that the material conversion tailwinds are currently unable to outrun the slowdown in single-family residential starts.
Macro Backdrop Driving Cautious Outlook
Management explicitly cited 'geopolitical uncertainty, elevated interest rates and resulting economic uncertainty' as headwinds for FY27. While non-residential construction benefits from large infrastructure projects, the residential side has visibly slowed. The company will rely heavily on infrastructure dollars and new geographic expansions to offset residential weakness.
Material Conversion via Advanced Recycling
To combat inflationary pressure on a dollar-for-dollar basis, management is utilizing its North American leading recycling capabilities. By pivoting to lower-cost, recycled materials rather than virgin resin, ADS is maintaining its pricing leverage and protecting its gross margins (which expanded to 37.3% YTD in Q3) despite the challenging demand environment.
Other KPIs
A massive improvement from $368.5M in FY25. This 54% jump in Free Cash Flow showcases the underlying strength of the business model and working capital management, allowing the company to return $155.4M to shareholders while funding elevated CapEx and strategic M&A.
Up 5.0% YoY, but lagging the 9.9% revenue growth. This indicates slight gross margin compression in the quarter, though full-year gross profit grew 6.7% due to favorable volume, price/cost dynamics, and the high-margin mix of Infiltrator sales.
Surged by $586.5M from the prior year, directly funding the NDS acquisition. Despite the heavy borrowing, the leverage ratio sits at a very manageable 1.6x, leaving the company with nearly $1.0B in total liquidity to weather any potential economic storms.
Guidance
Accelerating. The midpoint of $3.45B implies a healthy ~13% YoY growth rate over FY26's $3.05B. However, this acceleration is almost entirely driven by the inorganic addition of a full year of NDS revenue rather than a sudden recovery in organic demand.
Decelerating. The midpoint of $1.025B implies a 6.4% YoY growth rate, which trails the projected 13% revenue growth. This implies management expects Adjusted EBITDA margins to compress from 31.6% in FY26 to approximately 29.7% in FY27, likely due to the integration of lower-margin NDS business and ongoing inflation.
Stable to slightly declining. Down from the $249.7M spent in FY26. This indicates the company is normalizing its infrastructure investments after heavy capacity and safety upgrades over the last 24 months, which will further bolster Free Cash Flow generation.
Key Questions
Organic vs. Inorganic Assumptions
With the FY27 revenue guidance implying 13% growth, how much of that is purely the annualized contribution from NDS, and what is the underlying organic volume growth assumption for the core pipe business?
SG&A Normalization Timeline
SG&A spiked to over 20% of sales this quarter due to M&A transaction costs. When does management expect SG&A margins to normalize back to historical levels, and what are the specific integration milestones for NDS?
Wastewater Segment Health
The Wastewater segment grew over 20% in the first half of the year but dropped to 3.7% in Q4. Is this purely a function of difficult comparables, or has there been a structural step-down in residential demand for Infiltrator products?